You are here

Isodiol International Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
ISOL
CSE Index: 
Currency: 

Isodiol International Inc. ("Isodiol"), focused on the nutritional health benefits  derived from hemp, is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Isodiol has received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products. 

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and aggressively continue international expansion into Latin America, Asia, and Europe.

You are here

Isodiol International Inc. (ISOL)

SEDAR Information

Company Info

Address
Suite 2200, 885 West Georgia Street
Vancouver, BC V6C 3E8
Canada
Phone
604-409-4409
Email
ir@isodiol.com
Website
https://isodiol.com/
Listing date
Tuesday, July 8, 2014
Transfer Agent
Computershare Investor Services Inc.
Email
ir@isodiol.com
Auditor
Davidson & Company LLP, Chartered Professional Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
98,334,359
Reserved for Issuance: 
5,224,134

Company Officers

Marcos Agramont, Chief Executive Officer, Chief Operating Officer
Andrew Alvis, President

Bulletins

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-08-11_TechTues_MedicalDevices_Website

Tech Tuesdays

Tuesday, August 11, 2020 -
4:15pm to 5:00pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm